SRGA Nasdaq

Surgalign Holdings, Inc.

SRGA | $0.1829 -50.36% 8.7M

(0.0% 1d) (0.0% 1m) (-76.9% 1y) (0.0% 2d) (-9.1% 3d) (0.0% 7d) (-54.59% volume)
Earnings Calendar: 2023-08-08
Market Cap: $ 1,690,130
http://www.surgalign.com
Sec Filling | Patents | 935 employees

Surgalign Holdings, Inc. is a global medical technology company, which engages in designing, developing and manufacturing biologic metal and synthetic implants worldwide. It focuses on delivering spine solutions that drive clinical and economic outcomes. The company markets its products throughout the United States and other countries worldwide through an expanding network of independent distributors. The company was founded in February 1998 and is headquartered in Deerfield, IL.

add to watch list Paper trade email alert is off

Press-releases

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Published: 2024-04-01 (Crawled : 11:00) - globenewswire.com
XTNT | $0.83 -0.86% 0.0% 120K

Health Technology

| -32.17% | O: -9.57% H: 0.0% C: 0.0%
year million revenue medical

Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist
cangaroorm fda clearance

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
Published: 2023-11-09 (Crawled : 14:00) - globenewswire.com
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist
business

Xtant Medical Announces Record Third Quarter Revenue of $25 Million
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
XTNT | $0.83 -0.86% 0.0% 120K

Health Technology

| -35.54% | O: 4.13% H: 4.75% C: -6.35%
revenue medical

Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business
Published: 2023-10-08 (Crawled : 00:20) - biospace.com/
XTNT | $0.83 -0.86% 0.0% 120K

Health Technology

| Email alert Add to watchlist
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist
business acquisition medical

Elutia Announces Private Placement for Proceeds Up to $26 Million
Published: 2023-09-19 (Crawled : 13:00) - globenewswire.com
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
Published: 2023-09-18 (Crawled : 20:00) - globenewswire.com
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist
business

Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
Published: 2023-09-06 (Crawled : 20:00) - globenewswire.com
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist
drug

Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
Published: 2023-08-30 (Crawled : 13:00) - globenewswire.com
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist
cangaroo publication study benefits

Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
Published: 2023-08-14 (Crawled : 20:00) - globenewswire.com
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| Email alert Add to watchlist
financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001209191-23-049692	4	2023-09-18	2023-09-15	Sell	F	1329	83307
0001209191-23-048058	4	2023-09-05	2023-09-01	Sell	F	2191	28809
0001209191-23-046085	4	2023-08-16	2023-08-15	Sell	F	2295	26039
0001209191-23-046083	4	2023-08-16	2023-08-15	Sell	F	5541	26022